Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Myriad Genetics (MYGN) Shares Repurchased: 2010-2016

Historic Shares Repurchased for Myriad Genetics (MYGN) over the last 6 years, with Dec 2016 value amounting to $10.3 million.

  • Myriad Genetics' Shares Repurchased fell 58.63% to $10.3 million in Q4 2016 from the same period last year, while for Dec 2016 it was $131.3 million, marking a year-over-year decrease of 22.63%. This contributed to the annual value of $50.0 million for FY2019, which is N/A change from last year.
  • According to the latest figures from Q4 2016, Myriad Genetics' Shares Repurchased is $10.3 million, which was down 51.64% from $21.3 million recorded in Q3 2016.
  • Myriad Genetics' 5-year Shares Repurchased high stood at $102.3 million for Q3 2013, and its period low was $10.3 million during Q4 2016.
  • For the 3-year period, Myriad Genetics' Shares Repurchased averaged around $42.7 million, with its median value being $44.9 million (2015).
  • In the last 5 years, Myriad Genetics' Shares Repurchased tumbled by 86.37% in 2012 and then spiked by 273.36% in 2013.
  • Quarterly analysis of 5 years shows Myriad Genetics' Shares Repurchased stood at $33.7 million in 2012, then spiked by 130.99% to $77.8 million in 2013, then decreased by 25.07% to $58.3 million in 2014, then crashed by 57.29% to $24.9 million in 2015, then tumbled by 58.63% to $10.3 million in 2016.
  • Its last three reported values are $10.3 million in Q4 2016, $21.3 million for Q3 2016, and $54.7 million during Q2 2016.